Talarozole
CAS No. 201410-53-9
Talarozole ( R115866 )
Catalog No. M20727 CAS No. 201410-53-9
Talarozole is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM respectively.Talarozole for the treatment of acne psoriasis and other keratinization disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 87 | In Stock |
|
5MG | 123 | In Stock |
|
10MG | 159 | In Stock |
|
25MG | 257 | In Stock |
|
50MG | 354 | In Stock |
|
100MG | 527 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTalarozole
-
NoteResearch use only not for human use.
-
Brief DescriptionTalarozole is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM respectively.Talarozole for the treatment of acne psoriasis and other keratinization disorders.
-
DescriptionTalarozole is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM respectively.Talarozole for the treatment of acne psoriasis and other keratinization disorders.
-
SynonymsR115866
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorRAMBA;CYP
-
Research AreaInfection
-
IndicationAcne; Psoriasis
Chemical Information
-
CAS Number201410-53-9
-
Formula Weight377.51
-
Molecular FormulaC21H23N5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:36 mg/mL (95.36 mM)
-
SMILESCCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Elizabeth Pavez Loriè Chamcheu J C Vahlquist A et al. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis[J]. Archives of Dermatological Research 2009 301(7):475-485.
molnova catalog
related products
-
Graveoline
Graveoline is an apoptosis and autophagy inducer in skin melanoma cancer cells.
-
ARN-5187
A novel lysosomotropic REV-ERB ligand that has a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy.
-
Cysteamine
An agent for the treatment of nephropathic cystinosis and an antioxidant.